EUVIMEDEUVIMED entdecken
Crossref

Uridine-Based PET/NIRF Dual-Modality imaging for precision tumor diagnosis and surgery

Linjie Bian, Panli Li, Yigang Chen, Simin He, Jianping Zhang, Xiaoping Xu, Jindian Li, Shaoli Song iD

European Journal of Nuclear Medicine and Molecular Imaging · 2026-02 · 53 (3) · 1765-1781

DOI: 10.1007/s00259-025-07573-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 24.09.2025. Verfasst von Linjie Bian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai…. Hauptthemen laut MEDLINE: Uridine, Positron Emission Tomography Computed Tomography, Precision Medicine, Optical Imaging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: the State Key Program of the National Natural Science Foundation of China, Shanghai Scientific and Technological Innovation Program, National Isotope Engineering Technology Research Center Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Metabolic reprogramming allows cancer cells to survive and proliferate under nutrient-deprived conditions. Uridine, a central molecule in pyrimidine metabolism, supports both nucleotide biosynthesis and redox homeostasis. However, high-sensitivity imaging tools for equilibrative nucleoside transporter 1 (ENT1)-mediated uridine transport are lacking, limiting applications in precise diagnosis and intraoperative guidance. This study aimed to develop and validate a novel dual-modality imaging platform targeting ENT1-mediated uridine transport for tumor imaging and surgical navigation. METHODS: We synthesized [68Ga]Ga-DOTA-FZUD and ICG-FZUD probes for PET and NIR-II fluorescence imaging, respectively. Small-animal PET/CT and NIR-II fluorescence imaging were performed, and biodistribution were analyzed. Ex vivo NIR-II fluorescence imaging using ICG-FZUD was performed on surgical specimens from three gastric cancer patients to confirm tumor targeting. RESULTS: [68Ga]Ga-DOTA-FZUD exhibited excellent radiochemical purity. In pancreatic cancer models with relatively higher ENT1 expression (AsPC-1, Panc-1) compared with lower ENT1 expression models (MiaPaCa-2, BxPC-3), [68Ga]Ga-DOTA-FZUD demonstrated markedly greater tumor uptake. Similar uptake was also observed in gastric, breast, and glioblastoma models, with tumor-to-muscle ratios consistently exceeding 3.5. ICG-FZUD enabled high-contrast NIR-II imaging and clearly delineated tumor margins. Notably, ICG-FZUD penetrated the blood-brain barrier and visualized orthotopic glioblastoma. Ex vivo imaging of human gastric cancer tissues confirmed selective tumor uptake, consistent with histopathological findings. CONCLUSION: This ENT1-targeted uridine transport PET/NIRF dual-modality imaging platform complements conventional glucose-based imaging and provides real-time intraoperative navigation. It holds significant promise for early cancer diagnosis and precision surgery with strong translational potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UridinePositron Emission Tomography Computed TomographyPrecision MedicineOptical ImagingHumansAnimalsMiceCell Line, TumorEquilibrative Nucleoside Transporter 1Tissue DistributionFemale

Stichwörter der Autor:innen

Dual-modality imagingImage-guided surgeryMolecular imagingNIR-II fluorescenceUridine metabolism

Substanzen

UridineEquilibrative Nucleoside Transporter 1

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, China.
  • Center for Biomedical Imaging, Fudan University, Shanghai, 200032, China.
  • Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Fudan University, Shanghai, 200433, China.
  • Department of General Surgery, The Affiliated Wuxi Central Hospital of Jiangnan University, Wuxi, Jiangsu, 214100, China.
  • Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. jindianli99@126.com.

ORCID-Profile: Shaoli Song

Förderung

  • the State Key Program of the National Natural Science Foundation of China
  • Shanghai Scientific and Technological Innovation Program
  • National Isotope Engineering Technology Research Center Funding
  • the construction project of Shanghai Key Laboratory of Molecular Imaging
  • Shanghai Pujiang Program

Zitieren

APA

Bian, L., Li, P., Chen, Y., He, S., Zhang, J., Xu, X., Li, J., & Song, S. (2026). Uridine-Based PET/NIRF Dual-Modality imaging for precision tumor diagnosis and surgery. European Journal of Nuclear Medicine and Molecular Imaging, 53(3), 1765-1781. https://doi.org/10.1007/s00259-025-07573-9

Vancouver

Bian L, Li P, Chen Y, He S, Zhang J, Xu X, et al. Uridine-Based PET/NIRF Dual-Modality imaging for precision tumor diagnosis and surgery. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(3):1765-1781. doi:10.1007/s00259-025-07573-9

BibTeX
@article{Bian2026,
  author = {Bian, Linjie and Li, Panli and Chen, Yigang and He, Simin and Zhang, Jianping and Xu, Xiaoping and Li, Jindian and Song, Shaoli},
  title = {Uridine-Based PET/NIRF Dual-Modality imaging for precision tumor diagnosis and surgery},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {3},
  pages = {1765--1781},
  doi = {10.1007/s00259-025-07573-9}
}
Kostenlos starten →